Evidence map›Paper›PMID 38362428›Full record

ArticleChemical science2024

Oxime metathesis: tuneable and versatile chemistry for dynamic networks.

Luca Pettazzoni, Marta Ximenis, Francesca Leonelli, Giulia Vozzolo, Enrico Bodo, Fermin Elizalde, Haritz Sardon

Abstract read
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luca PettazzoniDepartment of Chemistry, Sapienza Università di Roma Piazzale Aldo Moro 5 00185 Rome Italy.
Marta XimenisPOLYMAT University of the Basque Country UPV/EHU Joxe Mari Korta Center, Avda. Tolosa 72 20018 Donostia-San Sebastian Spain haritz.sardon@ehu.eus.ORCID https://orcid.org/0000-0002-6550-6307
Francesca LeonelliDepartment of Chemistry, Sapienza Università di Roma Piazzale Aldo Moro 5 00185 Rome Italy.ORCID https://orcid.org/0000-0002-4135-5727
Giulia VozzoloPOLYMAT University of the Basque Country UPV/EHU Joxe Mari Korta Center, Avda. Tolosa 72 20018 Donostia-San Sebastian Spain haritz.sardon@ehu.eus.
Enrico BodoDepartment of Chemistry, Sapienza Università di Roma Piazzale Aldo Moro 5 00185 Rome Italy.ORCID https://orcid.org/0000-0001-8449-4711
Fermin ElizaldePOLYMAT University of the Basque Country UPV/EHU Joxe Mari Korta Center, Avda. Tolosa 72 20018 Donostia-San Sebastian Spain haritz.sardon@ehu.eus.
Haritz SardonPOLYMAT University of the Basque Country UPV/EHU Joxe Mari Korta Center, Avda. Tolosa 72 20018 Donostia-San Sebastian Spain haritz.sardon@ehu.eus.ORCID https://orcid.org/0000-0002-6268-0916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxime chemistry has emerged as a versatile tool for use in a wide range of applications. In particular, the combination of oximes with esters and urethanes has enabled the realisation of Covalent Adaptable Networks (CANs) with improved and tunable dynamic properties. Nevertheless, an exclusively oxime-based chemistry has not yet been explored in the fabrication of CANs. In this work, we investigate the mechanism of the acid-catalysed dynamic exchange of oximes. We propose a metathesis mechanism that is well supported by both experimental and computational studies, which highlight the importance of the substituent effect on the exchange reaction kinetics. Then, as a proof of concept, we incorporate oxime groups into a cross-linked polymeric material and demonstrate the ability of oxime-based polymers to be reprocessed under acid catalysis while maintaining their structural integrity.

Identifiers

PMID38362428
PMCPMC10866338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.